Ohh well , win some lose some, still got halo & xoma ....think I got June calls , afraid to look , so maybe..gl
XOMA? never buy stocks that had a reverse split, another one is sure to follow.
I saw it too. Actually the statement said : Progenics prostate cancer drug unlikely suitable for Phase 3 test --says Stifel. Look for support at the $4.30 level.
That really shouldn't be a surprise. I'm long but would you throw millions and millions of dollars at a Phase 3 given what the abstract said. Let's try and be objective here.
This is not news... this is more short attacks.. jesus
Stifel maintains its Hold rating on Progenics.